Status:
COMPLETED
Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Infiltrative Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the performance of a double labelling method using isotope and methylene blue dye injection to localize precisely Sentinel Lymph Node (SLN) in a series of 100 pati...
Eligibility Criteria
Inclusion
- patients with infiltrative breast cancer (diagnosed pre-operatively by core biopsy)
- approval and informed consent
Exclusion
- chemotherapy
- locoregional radiotherapy
- prevalent axillary lymph node
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00314405
Start Date
April 1 2006
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gynécologie-Obstétrique, Hôpital Civil
Strasbourg, France, 67091